Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph A Tangrea

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Epigenetics|November 14, 2007
CD44 and PTGS2 methylation are independent prognostic markers for biochemical recurrence among prostate cancer patients with clinically localized diseaseKaren Woodson, Keith J O'Reilly, David E Ward, et al.
Biochemical Genetics|October 9, 2010
Lack of association of the N-acetyltransferase NAT1*10 allele with prostate cancer incidence, grade, or stage among smokers in FinlandLaCreis R Kidd, David W Hein, Karen Woodson, et al.
The Prostate|May 7, 2004
Heterogeneous gene methylation patterns among pre-invasive and cancerous lesions of the prostate: a histopathologic study of whole mount prostate specimensKaren Woodson, John Gillespie, Jeffrey Hanson, et al.
International Journal of Cancer|March 29, 2002
Physical activity and lung cancer risk in male smokersLisa H Colbert, Terryl J Hartman, Joseph A Tangrea, et al.
Cancer Letters|March 6, 2003
Polymorphisms in the DNA repair genes XPD, XRCC1, XRCC3, and APE/ref-1, and the risk of lung cancer among male smokers in FinlandR Rita Misra, Duminda Ratnasinghe, Joseph A Tangrea, et al.
Cancer Causes & Control : CCC|September 2, 2003
Manganese superoxide dismutase (MnSOD) polymorphism, alpha-tocopherol supplementation and prostate cancer risk in the alpha-tocopherol, beta-carotene cancer prevention study (Finland)Karen Woodson, Joseph A Tangrea, Teresa A Lehman, et al.
Cancer Prevention Research (Philadelphia, Pa.)|November 3, 2011
Randomized, double-blind, placebo-controlled trial of polyphenon E in prostate cancer patients before prostatectomy: evaluation of potential chemopreventive activitiesMike M Nguyen, Frederick R Ahmann, Raymond B Nagle, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 10, 2004
Serum carotenoids and alpha-tocopherol and risk of nonmelanoma skin cancerJoanne F Dorgan, Naana A Boakye, Thomas R Fears, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 20, 2014
Soy food frequency questionnaire does not correlate with baseline isoflavone levels in patients with bladder cancerJill M Kolesar, Marcia Pomplun, Tom Havighurst, et al.
Journal of the National Cancer Institute|February 16, 2006
Gene promoter methylation in prostate tumor-associated stromal cellsJeffrey A Hanson, John W Gillespie, Amelia Grover, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Epigenetics|November 14, 2007
CD44 and PTGS2 methylation are independent prognostic markers for biochemical recurrence among prostate cancer patients with clinically localized diseaseKaren Woodson, Keith J O'Reilly, David E Ward, et al.
Biochemical Genetics|October 9, 2010
Lack of association of the N-acetyltransferase NAT1*10 allele with prostate cancer incidence, grade, or stage among smokers in FinlandLaCreis R Kidd, David W Hein, Karen Woodson, et al.
The Prostate|May 7, 2004
Heterogeneous gene methylation patterns among pre-invasive and cancerous lesions of the prostate: a histopathologic study of whole mount prostate specimensKaren Woodson, John Gillespie, Jeffrey Hanson, et al.
International Journal of Cancer|March 29, 2002
Physical activity and lung cancer risk in male smokersLisa H Colbert, Terryl J Hartman, Joseph A Tangrea, et al.
Cancer Letters|March 6, 2003
Polymorphisms in the DNA repair genes XPD, XRCC1, XRCC3, and APE/ref-1, and the risk of lung cancer among male smokers in FinlandR Rita Misra, Duminda Ratnasinghe, Joseph A Tangrea, et al.
Cancer Causes & Control : CCC|September 2, 2003
Manganese superoxide dismutase (MnSOD) polymorphism, alpha-tocopherol supplementation and prostate cancer risk in the alpha-tocopherol, beta-carotene cancer prevention study (Finland)Karen Woodson, Joseph A Tangrea, Teresa A Lehman, et al.
Cancer Prevention Research (Philadelphia, Pa.)|November 3, 2011
Randomized, double-blind, placebo-controlled trial of polyphenon E in prostate cancer patients before prostatectomy: evaluation of potential chemopreventive activitiesMike M Nguyen, Frederick R Ahmann, Raymond B Nagle, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 10, 2004
Serum carotenoids and alpha-tocopherol and risk of nonmelanoma skin cancerJoanne F Dorgan, Naana A Boakye, Thomas R Fears, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 20, 2014
Soy food frequency questionnaire does not correlate with baseline isoflavone levels in patients with bladder cancerJill M Kolesar, Marcia Pomplun, Tom Havighurst, et al.
Journal of the National Cancer Institute|February 16, 2006
Gene promoter methylation in prostate tumor-associated stromal cellsJeffrey A Hanson, John W Gillespie, Amelia Grover, et al.
Pageof 3